Articles

  • Sep 4, 2024 | jamanetwork.com | Dost Ongur

    Commercial Interests and EEG Data Collection The article by Etkin and Mathalon1 argues that electroencephalography (EEG) is an underused modality for biomarker development in psychiatry research and calls for its broader utilization. Etkin has disclosed that he receives salary and equity from Alto Neuroscience, a for-profit entity developing new medications using predictive biomarkers including EEG.

  • Aug 22, 2024 | healio.com | Moira Mahoney |Bob Herpen |Dost Ongur

    Read more You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

  • May 22, 2024 | jamanetwork.com | Kara S. Bagot |Dost Ongur |Kirsten Bibbins-Domingo |Annette Flanagin

    Advancing Diversity, Equity, and Inclusion at JAMA Psychiatry Recently, Kirsten Bibbins-Domingo, MD, PhD, MAS, Editor of JAMA and the JAMA Network, and the editors and diversity, equity, and inclusion (DEI) editors from JAMA and the JAMA Network specialty journals, including JAMA Psychiatry, coauthored an article affirming the JAMA Network’s commitment to DEI and reviewing markers of progress in the makeup of the editorial boards across the network.1 For JAMA Psychiatry specifically, more...

  • May 21, 2024 | psychiatrictimes.com | Dost Ongur

    CONFERENCE REPORTER“Conditions such as schizophrenia and some kinds of bipolar disorder are common and severe disorders, and existing treatments are only partially effective and associated with significant side effects.

  • Mar 20, 2024 | jamanetwork.com | Dost Ongur

    JAMA Psychiatry Peer Reviewers in 2023 We sincerely thank the 659 peer reviewers who completed manuscript reviews for JAMA Psychiatry in 2023. Camilo de la Fuente-Sandoval Kristina M.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →